316 related articles for article (PubMed ID: 17404898)
1. Predicting quality of life impairment in chronic schizophrenia from cognitive variables.
Ritsner MS
Qual Life Res; 2007 Aug; 16(6):929-37. PubMed ID: 17404898
[TBL] [Abstract][Full Text] [Related]
2. Cognitive deficits and its relation with psychopathology and global functioning in first episode schizophrenia.
Hegde S; Thirthalli J; Rao SL; Raguram A; Philip M; Gangadhar BN
Asian J Psychiatr; 2013 Dec; 6(6):537-43. PubMed ID: 24309868
[TBL] [Abstract][Full Text] [Related]
3. Temporal relationship between change in cognition and change in functioning in schizophrenia.
Fiszdon JM; Choi J; Goulet J; Bell MD
Schizophr Res; 2008 Oct; 105(1-3):105-13. PubMed ID: 18657398
[TBL] [Abstract][Full Text] [Related]
4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
5. Anhedonia is an important factor of health-related quality-of-life deficit in schizophrenia and schizoaffective disorder.
Ritsner MS; Arbitman M; Lisker A
J Nerv Ment Dis; 2011 Nov; 199(11):845-53. PubMed ID: 22048136
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive Impairments in Deficit and Non-Deficit Schizophrenia and Their Relationships with Symptom Dimensions and Other Clinical Variables.
Yu M; Tang X; Wang X; Zhang X; Zhang X; Sha W; Yao S; Shu N; Zhang X; Zhang Z
PLoS One; 2015; 10(9):e0138357. PubMed ID: 26381645
[TBL] [Abstract][Full Text] [Related]
7. The influence of neurocognitive deficits and symptoms on disability in schizophrenia.
Ertuğrul A; Uluğ B
Acta Psychiatr Scand; 2002 Mar; 105(3):196-201. PubMed ID: 11939973
[TBL] [Abstract][Full Text] [Related]
8. [Subjective cognition in schizophrenia].
Potvin S; Aubin G; Stip E
Encephale; 2017 Feb; 43(1):15-20. PubMed ID: 26923995
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in stable schizophrenia: the relative contributions of disorganization and cognitive dysfunction.
Sigaudo M; Crivelli B; Castagna F; Giugiario M; Mingrone C; Montemagni C; Rocca G; Rocca P
Schizophr Res; 2014 Mar; 153(1-3):196-203. PubMed ID: 24485197
[TBL] [Abstract][Full Text] [Related]
10. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
Kake TR; Garrett N; Te Aonui M
Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
[TBL] [Abstract][Full Text] [Related]
11. Cognitive performance and quality of life early in the course of bipolar disorder.
Mackala SA; Torres IJ; Kozicky J; Michalak EE; Yatham LN
J Affect Disord; 2014 Oct; 168():119-24. PubMed ID: 25043323
[TBL] [Abstract][Full Text] [Related]
12. Community dysfunction in schizophrenia: rate-limiting factors.
Bozikas VP; Kosmidis MH; Kafantari A; Gamvrula K; Vasiliadou E; Petrikis P; Fokas K; Karavatos A
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):463-70. PubMed ID: 16442195
[TBL] [Abstract][Full Text] [Related]
13. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
Savilla K; Kettler L; Galletly C
Aust N Z J Psychiatry; 2008 Jun; 42(6):496-504. PubMed ID: 18465376
[TBL] [Abstract][Full Text] [Related]
14. The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia.
Heslegrave RJ; Awad AG; Voruganti LN
J Psychiatry Neurosci; 1997 Jul; 22(4):235-43. PubMed ID: 9262045
[TBL] [Abstract][Full Text] [Related]
15. General and social cognition in first episode schizophrenia: identification of separable factors and prediction of functional outcome using the IntegNeuro test battery.
Williams LM; Whitford TJ; Flynn G; Wong W; Liddell BJ; Silverstein S; Galletly C; Harris AW; Gordon E
Schizophr Res; 2008 Feb; 99(1-3):182-91. PubMed ID: 18053688
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychological and functional correlates of clock-drawing test in elderly institutionalized patients with schizophrenia.
Okamura A; Kitabayashi Y; Kohigashi M; Shibata K; Ishida T; Narumoto J; Morioka C; Kitabayashi M; Kashima A; Tani N; Nakaaki S; Mimura M; Fukui K
Psychogeriatrics; 2012 Dec; 12(4):242-7. PubMed ID: 23279146
[TBL] [Abstract][Full Text] [Related]
17. [Differentiation of deficit and non-deficit schizophrenia based on cognitive functions].
Polgár P
Ideggyogy Sz; 2011 Mar; 64(3-4):128-32. PubMed ID: 21545010
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.
Sánchez-Morla EM; Barabash A; Martínez-Vizcaíno V; Tabarés-Seisdedos R; Balanzá-Martínez V; Cabranes-Díaz JA; Baca-Baldomero E; Gómez JL
Psychiatry Res; 2009 Oct; 169(3):220-8. PubMed ID: 19758705
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Tryptophan Catabolites on Negative Symptoms and Deficit Schizophrenia are Partly Mediated by Executive Impairments: Results of Partial Least Squares Path Modeling.
Kanchanatawan B; Maes M
CNS Neurol Disord Drug Targets; 2018; 17(6):473-486. PubMed ID: 29968545
[TBL] [Abstract][Full Text] [Related]
20. General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia.
Réthelyi JM; Czobor P; Polgár P; Mersich B; Bálint S; Jekkel E; Magyar K; Mészáros A; Fábián A; Bitter I
Eur Arch Psychiatry Clin Neurosci; 2012 Mar; 262(2):107-15. PubMed ID: 21792534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
